Coronary re- vascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]). Am J Cardiol. 2010;106:498 503. 139. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884 893. 140. Thune JJ, Signorovitch J, Kober L, Velasquez EJ, McMurray JJV, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MC, Solomon SD. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension. 2008;51:48 54. 141. Denardo SJ, Anderson RD, Pepine CJ. Blood pressure targets after high-risk myocardial infarction; is it time to update the guidelines? Hypertension. 2008;51:26 27. 142. Bangalore S, Messerli FH, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC; Treating to New Targets Steering Committee and Investigators. J-curve revisited: an analysis of blood pressure and cardio- vascular events in the Treating to New Targets (TNT) Trial. Eur Heart J. 2010;31:2897 2908. 143. Dorresteijn JAN, van der Graaf Y, Spiering W, Grobbee DE, Bots ML, Visseren FLJ; Secondary Manifestations of Arterial Disease Study Group. Relation between blood pressure and vascular events and mor- tality in patients with manifest vascular disease: J-curve revisited. Hypertension. 2012;59:14 21. 144. Waller PC, Isles CG, Lever AF, Murray GD, McInnes GT. Does thera- peutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens. 1988;2:7 10. 145. Fletcher A, Beevers DG, Bulpitt CJ, Butler A, Coles EC, Hunt D, Munro- Faure AD, Newson R, O Riordan PW, Petri JC, et al. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens. 1988;2:11 15. 146. 